| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.54B | 18.91B | 16.49B | 13.52B | 11.22B | 11.49B |
| Gross Profit | 4.80B | 4.22B | 3.62B | 2.69B | 2.14B | 1.11B |
| EBITDA | 4.23B | 3.48B | 3.74B | 1.25B | 996.00M | 222.00M |
| Net Income | 5.79B | 2.52B | 2.41B | -1.27B | 120.00M | -3.17B |
Balance Sheet | ||||||
| Total Assets | 37.94B | 35.69B | 31.51B | 29.45B | 28.67B | 29.52B |
| Cash, Cash Equivalents and Short-Term Investments | 6.13B | 5.36B | 3.52B | 2.40B | 2.55B | 3.31B |
| Total Debt | 5.04B | 5.13B | 5.76B | 5.96B | 7.78B | 7.33B |
| Total Liabilities | 35.51B | 36.57B | 35.14B | 35.47B | 33.31B | 34.39B |
| Stockholders Equity | 2.41B | -912.00M | -3.68B | -6.05B | -4.66B | -4.90B |
Cash Flow | ||||||
| Free Cash Flow | 3.18B | 2.90B | 1.77B | 1.25B | -818.00M | -3.96B |
| Operating Cash Flow | 4.13B | 3.78B | 2.48B | 1.85B | -259.00M | -3.01B |
| Investing Cash Flow | -950.00M | -831.00M | -726.00M | 826.00M | -428.00M | -1.01B |
| Financing Cash Flow | -1.36B | -1.05B | -549.00M | -2.87B | -88.00M | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £22.14B | 21.12 | 18.88% | 1.71% | -3.66% | -9.01% | |
71 Outperform | $106.91B | 18.58 | 3725.44% | 0.91% | 9.62% | 146.74% | |
68 Neutral | £7.32B | 25.75 | 46.10% | 0.56% | 7.36% | 48.93% | |
66 Neutral | £8.11B | 29.89 | 12.85% | 1.93% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $59.56B | 31.02 | 17.59% | 1.99% | 11.60% | 8.03% | |
50 Neutral | £8.00B | 25.88 | 10.69% | 1.10% | -0.38% | ― |